Shingo Kurahashi

696 total citations
55 papers, 382 citations indexed

About

Shingo Kurahashi is a scholar working on Hematology, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Shingo Kurahashi has authored 55 papers receiving a total of 382 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Hematology, 11 papers in Oncology and 11 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Shingo Kurahashi's work include Acute Myeloid Leukemia Research (10 papers), Hematopoietic Stem Cell Transplantation (9 papers) and Chronic Myeloid Leukemia Treatments (7 papers). Shingo Kurahashi is often cited by papers focused on Acute Myeloid Leukemia Research (10 papers), Hematopoietic Stem Cell Transplantation (9 papers) and Chronic Myeloid Leukemia Treatments (7 papers). Shingo Kurahashi collaborates with scholars based in Japan, United States and China. Shingo Kurahashi's co-authors include Fumihiko Hayakawa, T Naoe, Norikazu Hashimoto, Naoto Ohi, Keiji Sugimoto, Yasuo Harada, Takahiko Yasuda, Tomoki Naoe, Isamu Sugiura and Shinobu Tsuzuki and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Shingo Kurahashi

43 papers receiving 371 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shingo Kurahashi Japan 12 138 134 109 67 65 55 382
Danielle Shafer United States 12 118 0.9× 151 1.1× 169 1.6× 48 0.7× 85 1.3× 30 398
Raya Mawad United States 13 264 1.9× 214 1.6× 127 1.2× 98 1.5× 52 0.8× 38 459
Neil Palmisiano United States 13 162 1.2× 228 1.7× 156 1.4× 120 1.8× 128 2.0× 64 491
Katharina Lisenko Germany 13 128 0.9× 77 0.6× 104 1.0× 41 0.6× 48 0.7× 24 309
Athanasios Galanopoulos Greece 10 211 1.5× 159 1.2× 115 1.1× 88 1.3× 46 0.7× 40 492
Mecide Gharibo United States 12 146 1.1× 197 1.5× 175 1.6× 49 0.7× 71 1.1× 34 400
Henning D. Popp Germany 12 181 1.3× 73 0.5× 141 1.3× 64 1.0× 26 0.4× 32 438
Sophie Rigaudeau France 11 238 1.7× 165 1.2× 125 1.1× 26 0.4× 66 1.0× 22 558
Xiaoqiong Tang China 11 79 0.6× 128 1.0× 158 1.4× 89 1.3× 36 0.6× 54 495

Countries citing papers authored by Shingo Kurahashi

Since Specialization
Citations

This map shows the geographic impact of Shingo Kurahashi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shingo Kurahashi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shingo Kurahashi more than expected).

Fields of papers citing papers by Shingo Kurahashi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shingo Kurahashi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shingo Kurahashi. The network helps show where Shingo Kurahashi may publish in the future.

Co-authorship network of co-authors of Shingo Kurahashi

This figure shows the co-authorship network connecting the top 25 collaborators of Shingo Kurahashi. A scholar is included among the top collaborators of Shingo Kurahashi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shingo Kurahashi. Shingo Kurahashi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Izutsu, Koji, Takayuki Ishikawa, Kazuyuki Shimada, et al.. (2025). Zanubrutinib in Japanese treatment-naive and relapsed/refractory patients with Waldenström macroglobulinemia and CLL/SLL. International Journal of Hematology. 121(4). 483–493. 1 indexed citations
2.
Terakura, Seitaro, Yuki Takeuchi, Takahiko Sato, et al.. (2025). Adjustment of low-dose ATG exposure improves outcomes in allogeneic hematopoietic stem cell transplantation: a prospective multicenter study. Cytotherapy. 27(8). 962–972.
3.
Kurahashi, Shingo, et al.. (2024). Risk factors for nonunion in femoral neck fracture patients with internal fixation: A multicenter (TRON group) retrospective study. Journal of Orthopaedic Science. 30(4). 672–677.
4.
Takahashi, Hiroshi, et al.. (2023). Effectiveness of Specific Single-Use Incisional Negative Pressure Wound Therapy (PICO System) After Major Lower Extremity Amputation. The International Journal of Lower Extremity Wounds. 24(1). 130–134. 3 indexed citations
5.
Watanabe, Miki, Yutaro Suzuki, Rie Ito, et al.. (2023). End-of-Life Care of Acute Myeloid Leukemia Compared with Aggressive lymphoma in Patients Who Are Eligible for Intensive Chemotherapy: An Observational Study in a Japanese Community Hospital. SHILAP Revista de lepidopterología. 4(1). 71–78. 1 indexed citations
6.
7.
Takahashi, Hiroshi, et al.. (2023). Posterior sternoclavicular joint dislocation with thoracic costovertebral joints fracture-dislocations: A case report. Trauma Case Reports. 43. 100766–100766.
8.
Kuwana, Masataka, Tomoki� Ito, Shugo Kowata, et al.. (2022). Fostamatinib for the treatment of Japanese patients with primary immune thrombocytopenia: A phase 3, placebo‐controlled, double‐blind, parallel‐group study. British Journal of Haematology. 200(6). 802–811. 9 indexed citations
9.
10.
11.
Kurahashi, Shingo, et al.. (2021). Plate fixation of acromion fracture using a mesh plate. Trauma Case Reports. 33. 100470–100470. 3 indexed citations
12.
Kawashima, Naomi, Satoshi Nishiwaki, N Shimizu, et al.. (2018). Outcomes of strategic alternative donor selection or suspending donor search based on Japan Marrow Donor Program coordination status. International Journal of Hematology. 107(5). 551–558.
13.
Takamatsu, Hiroyuki, Takeshi Yamashita, Shingo Kurahashi, et al.. (2018). Clinical Implications of t(11;14) in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 25(3). 474–479. 13 indexed citations
14.
Koyama, Daisuke, Satoshi Nishiwaki, Satomi Yamamoto, et al.. (2017). Effective chemomobilization with etoposide and cytarabine (EC regimen) in lymphoma patients: a single-center, retrospective, observational study. Japanese Journal of Clinical Oncology. 47(9). 820–825. 1 indexed citations
15.
Kawashima, Naomi, Takahiko Sato, Aika Seto, et al.. (2016). Long-term outcomes of allogeneic hematopoietic cell transplantation with intensified myeloablative conditioning for refractory myeloid malignancy. Bone Marrow Transplantation. 51(6). 869–871. 3 indexed citations
16.
Kurahashi, Shingo & Tomoki Naoe. (2012). [Classification of acute myeloid leukemia].. PubMed. 70 Suppl 2. 384–8.
17.
Kurahashi, Shingo, Fumihiko Hayakawa, Yasuyoshi Miyata, et al.. (2011). PAX5–PML acts as a dual dominant-negative form of both PAX5 and PML. Oncogene. 30(15). 1822–1830. 31 indexed citations
18.
Sawai, Hirozumi, et al.. (1998). Angiomyolipoma of the liver: Case report and collective review of cases diagnosed from fine needle aspiration biopsy specimens. Journal of Hepato-Biliary-Pancreatic Surgery. 5(3). 333–338. 14 indexed citations
19.
Yotsuyanagi, Toshihisa, Shingo Kurahashi, Takaaki Saito, et al.. (1993). Delivery of Lymph Node‐targeted Adriamycin by Gastric Submucosal Liposomal Injection in Rabbits. Japanese Journal of Cancer Research. 84(2). 208–213. 6 indexed citations
20.
Kurahashi, Shingo, et al.. (1983). . Journal of the Society of Materials Science Japan. 32(352). 45–50.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Danielle Shafer Breakdown of academic impact, for papers by Raya Mawad Breakdown of academic impact, for papers by Neil Palmisiano Breakdown of academic impact, for papers by Katharina Lisenko Breakdown of academic impact, for papers by Athanasios Galanopoulos Breakdown of academic impact, for papers by Mecide Gharibo Breakdown of academic impact, for papers by Henning D. Popp Breakdown of academic impact, for papers by Sophie Rigaudeau Breakdown of academic impact, for papers by Xiaoqiong Tang
Rankless by CCL
2026